The efficacy and safety by injecting distilled water into lens capsule to prevent lens capsule opacification after cataract phacoemulsification

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046277

Enrollment

Unknown

Registered

2021-05-12

Start date

2021-06-06

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Control Group :normal cataract phacoemulsification

Experimental group1:inject distilled water and remain 120s

Experimental group:inject distilled water and remain 180s

Eligibility

Sex/Gender

All

Age

50 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 50 years; 2. Best corrected visual acuity <= 0.3; 3. Agreed to participate in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. History of ocular trauma; 2. Congenital cataract; 3. Subluxation of lens; 4. History of diabetes, high myopia, glaucoma, uveitis, ocular trauma, corneal transplantation and intraocular surgery.

Design outcomes

Primary

Measure	Time frame
score of posterior capsule opacification;	—

Countries

China

Contacts

Public ContactXie Zhenggao

Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

zgxie87@163.com+86 18051060800

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026